UNSPSC 51292910: Maroxepin

This classification denotes an antidepressant agent with the molecular formula C19H19NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XG4094G0OY, chemically known as 2,3,4,5-tetrahydro-3-methyl-1h-dibenz(2,3:6,7)oxepino(4,5-d)azepine but generally known as maroxepin, which bears US NIH Compound Identifier 68858. European Medicines Agency schedules Maroxepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08651MIG.

UNSPSC 51292910 Maroxepin is a Commodity code that captures pharmaceutical products and medical supplies procured by state and local health agencies, though recent solicitation activity under this code tag shows limited direct alignment with the code's nominal scope. Seminole County, Florida issued an IFB in June 2026 for naloxone and safe drug deactivation systems—emergency response and harm-reduction supplies rather than maroxepin specifically—suggesting the code may be applied inconsistently across jurisdictions or that the recent opportunity was mistagged. State and local procurement under this code tier typically involves health departments, county public health divisions, and community health agencies sourcing pharmaceutical inventory for clinical, emergency-response, or public-health initiatives.

The single recent opportunity on file is Seminole County's IFB60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023 (note: the posted date and due date are incongruent in the source, suggesting a data quality issue). Seminole County sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county's community health building in Sanford, Florida. The contract included a two-year initial term with a one-year renewal option, e-Verify compliance, workers' compensation and commercial general liability insurance, and potential FEMA funding with corresponding federal compliance requirements. Geographic activity under this code is presently limited to Florida based on available records; broader state and regional distribution cannot be determined from the current opportunity set.